Literature DB >> 9148243

Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum.

T Shishido1, Y Watanabe, H Suzuki, K Kato, S Niwa, J Hanoune, I Matsuoka.   

Abstract

Dopamine D1 receptor (D1R), D2 receptor (D2R) and adenylate cyclase type V (AC5) mRNAs in the rat dorsal striatum (CPu) and ventral striatum (Acb) were measured by in situ hybridization histochemistry (ISHH) after repeated methamphetamine (MAP) administration. MAP (4 mg/kg) or an equivalent volume of saline was administered intraperitoneally once daily for 10 days to male Wistar rats. After 7 days of abstinence, behavioral experiment with MAP-challenge revealed that a significant behavioral sensitization was achieved in MAP-treated animals. The animals were sacrificed 7 days after the last injection and brain sections were analyzed by ISHH using 35S-labeled antisense oligonucleotide probes. We found that D1R mRNA levels in the CPu were significantly increased (124% of control, P < 0.01). In contrast, repeated MAP-treatment did not significantly affect the expression of D1R mRNA in Acb or mRNA for D2R or AC5. It was concluded that MAP-induced behavioral sensitization is accompanied by increased D1R mRNA levels in CPu.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148243     DOI: 10.1016/s0304-3940(97)13376-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Methamphetamine reduces expression of caveolin-1 in the dorsal striatum: Implication for dysregulation of neuronal function.

Authors:  Sucharita S Somkuwar; McKenzie J Fannon; Brian P Head; Chitra D Mandyam
Journal:  Neuroscience       Date:  2016-04-30       Impact factor: 3.590

2.  Chronic methamphetamine exposure prior to middle cerebral artery occlusion increases infarct volume and worsens cognitive injury in Male mice.

Authors:  Damian G Zuloaga; Jianming Wang; Sydney Weber; Gregory P Mark; Stephanie J Murphy; Jacob Raber
Journal:  Metab Brain Dis       Date:  2016-03-28       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.